2020
DOI: 10.1016/j.jcct.2019.07.008
|View full text |Cite
|
Sign up to set email alerts
|

Assessing the value of coronary artery computed tomography as the first-line anatomical test for stable patients with indications for invasive angiography due to suspected coronary artery disease. Initial cost analysis in the CAT-CAD randomized trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
10
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 21 publications
0
10
0
Order By: Relevance
“…However, subgroup analysis did not yield any significant differences between the RCA-aorta angles of normal cases, or those with <50% and ≥50% coronary stenosis. Degree of coronary stenosis is commonly used in the current literature to characterise CAD severity (25,26,(28)(29)(30). However, this alone is not necessarily indicative of ischemic severity, which is an inherent limitation for CCTA, as the degree of coronary stenosis does not always translate to the hemodynamic significance of coronary lesions.…”
Section: Discussionmentioning
confidence: 99%
“…However, subgroup analysis did not yield any significant differences between the RCA-aorta angles of normal cases, or those with <50% and ≥50% coronary stenosis. Degree of coronary stenosis is commonly used in the current literature to characterise CAD severity (25,26,(28)(29)(30). However, this alone is not necessarily indicative of ischemic severity, which is an inherent limitation for CCTA, as the degree of coronary stenosis does not always translate to the hemodynamic significance of coronary lesions.…”
Section: Discussionmentioning
confidence: 99%
“… 23 Furthermore, this strategy would offer an estimated cost savings of US$1,149,712 even if all 794 patients underwent a CCTA as an alternative test (direct cost difference is US$1448 less for CCTA compared to invasive angiogram) every year in this health region. 24 Given that all 794 patients may not be candidates for CCTA (ie, atrial fibrillation as a contraindication in approximately 10%) or may have an inadequate assessment (ie, high calcium score), the real-world benefits may be more modest but still significant. External validation of this predictive model, incorporation into a user-friendly decision support program, and evaluation of implementation are required next steps prior to scale and spread of this model.…”
Section: Discussionmentioning
confidence: 99%
“…Sixty patients from the coronary CTA arm of the randomized CAT-CAD trial were analyzed. [2][3][4] Individuals with coronary artery stenoses in a range of 40% to 90% were selected and retrospectively evaluated with FFR-CT. Afterward, the investigators selected the most appropriate clinical management based on FFR-CT results in order to investigate the effect of noninvasive functional coronary assessment on the reclassification rate and management plan compared to the routine clinical management (Fig.…”
Section: Methodsmentioning
confidence: 99%